This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Sep 28:354:i5131.

doi: 10.1136/bmj.i5131.

Manufacturer failed to disclose faulty device in rivaroxaban trial

PMID: 27681119
DOI: 10.1136/bmj.i5131

Manufacturer failed to disclose faulty device in rivaroxaban trial

Deborah Cohen. BMJ. 2016.

. 2016 Sep 28:354:i5131.

doi: 10.1136/bmj.i5131.

Author

PMID: 27681119
DOI: 10.1136/bmj.i5131

No abstract available

PubMed Disclaimer

Similar articles

Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device.
Cohen D. Cohen D. BMJ. 2015 Dec 3;351:h6431. doi: 10.1136/bmj.h6431. BMJ. 2015. PMID: 26635138 No abstract available.
Fatal intracerebral bleeding under rivaroxaban.
Stöllberger C, Bastovansky A, Finsterer J. Stöllberger C, et al. Int J Cardiol. 2015 Dec 15;201:110-2. doi: 10.1016/j.ijcard.2015.06.081. Epub 2015 Jun 26. Int J Cardiol. 2015. PMID: 26296048 Review.
Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
Baruch L, Sherman O. Baruch L, et al. Ann Pharmacother. 2013 Sep;47(9):1210-2. doi: 10.1177/1060028013503129. Ann Pharmacother. 2013. PMID: 24259738
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban.
Douxfils J, Tamigniau A, Chatelain B, Chatelain C, Wallemacq P, Dogné JM, Mullier F. Douxfils J, et al. Thromb Haemost. 2013 Oct;110(4):723-31. doi: 10.1160/TH13-04-0274. Epub 2013 Jul 11. Thromb Haemost. 2013. PMID: 23846172
The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
Reddy P, Giugliano RP. Reddy P, et al. J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):526-32. doi: 10.1177/1074248414525505. Epub 2014 Mar 21. J Cardiovasc Pharmacol Ther. 2014. PMID: 24659084 Review.

See all similar articles

Cited by

Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.
Oskarsdottir AR, Gudmundsdottir BR, Jensdottir HM, Flygenring B, Palsson R, Onundarson PT. Oskarsdottir AR, et al. Blood. 2021 May 20;137(20):2745-2755. doi: 10.1182/blood.2020008698. Blood. 2021. PMID: 33512454 Free PMC article.
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savović J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R. López-López JA, et al. BMJ. 2017 Nov 28;359:j5058. doi: 10.1136/bmj.j5058. BMJ. 2017. PMID: 29183961 Free PMC article. Review.
Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.
Ueberham L, Dagres N, Potpara TS, Bollmann A, Hindricks G. Ueberham L, et al. Adv Ther. 2017 Oct;34(10):2274-2294. doi: 10.1007/s12325-017-0616-6. Epub 2017 Sep 27. Adv Ther. 2017. PMID: 28956288 Free PMC article. Review.
Management strategies for atrial fibrillation.
Patel PA, Ali N, Hogarth A, Tayebjee MH. Patel PA, et al. J R Soc Med. 2017 Jan;110(1):13-22. doi: 10.1177/0141076816677857. J R Soc Med. 2017. PMID: 28106485 Free PMC article. Review.

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations